Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET>BRAF+*** > Treatment > USA. G. Cobimetinib+Vemurafenib

---

USA. G. Cobimetinib+Vemurafenib's subsections
(*) AU; BR & CH Approval Date: ?
(*) CA Approval Date: 2016. 02.25
(*) EU Approval Date: 2015. 11.25
(*) USA Approval Date: 2015. 11.10
>or Unresectable
>with BRAF V600E or V600K Mutation
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2017. 10.10
TradeMark
TradeMark Web-Site

USA. G. Cobimetinib+Vemurafenib's products
This section has no products